Vident Advisory LLC Buys 8,195 Shares of Docusign Inc. $DOCU

Key Points

• Vident Advisory LLC has increased its stake in Docusign Inc. by 26.7%, now owning 38,872 shares valued at $3,164,000.
• Other institutional investors have also raised their positions in Docusign, with the Manufacturers Life Insurance Company growing its holdings by 222.9% in the last quarter.
• Docusign's recent quarterly earnings reported an EPS of $0.90, exceeding the consensus estimate and representing a 7.6% year-over-year increase in revenue.

Vident Advisory LLC lifted its stake in shares of Docusign Inc. (NASDAQ:DOCU - Free Report) by 26.7% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 38,872 shares of the company's stock after purchasing an additional 8,195 shares during the quarter. Vident Advisory LLC's holdings in Docusign were worth $3,164,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently made changes to their positions in the stock. American Century Companies Inc. boosted its position in shares of Docusign by 3.1% during the 1st quarter. American Century Companies Inc. now owns 5,477,758 shares of the company's stock worth $445,890,000 after purchasing an additional 162,299 shares in the last quarter. Wellington Management Group LLP boosted its position in shares of Docusign by 372.5% during the 1st quarter. Wellington Management Group LLP now owns 1,826,949 shares of the company's stock worth $148,714,000 after purchasing an additional 1,440,269 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its position in shares of Docusign by 3.0% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,709,807 shares of the company's stock worth $153,780,000 after purchasing an additional 50,440 shares in the last quarter. Charles Schwab Investment Management Inc. boosted its position in shares of Docusign by 6.7% during the 1st quarter. Charles Schwab Investment Management Inc. now owns 1,431,901 shares of the company's stock worth $116,557,000 after purchasing an additional 89,948 shares in the last quarter. Finally, Ameriprise Financial Inc. boosted its position in shares of Docusign by 24.7% during the 4th quarter. Ameriprise Financial Inc. now owns 1,186,106 shares of the company's stock worth $106,703,000 after purchasing an additional 235,145 shares in the last quarter. Institutional investors own 77.64% of the company's stock.

Insider Activity

In other Docusign news, CFO Blake Jeffrey Grayson sold 15,143 shares of Docusign stock in a transaction that occurred on Wednesday, June 18th. The shares were sold at an average price of $74.80, for a total transaction of $1,132,696.40. Following the transaction, the chief financial officer owned 110,723 shares of the company's stock, valued at $8,282,080.40. This trade represents a 12.03% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Allan C. Thygesen sold 40,000 shares of Docusign stock in a transaction that occurred on Tuesday, July 1st. The stock was sold at an average price of $77.51, for a total transaction of $3,100,400.00. Following the transaction, the chief executive officer directly owned 143,983 shares in the company, valued at approximately $11,160,122.33. This represents a 21.74% decrease in their position. The disclosure for this sale can be found here. Insiders sold 78,552 shares of company stock worth $5,983,631 in the last quarter. 1.01% of the stock is owned by corporate insiders.

Docusign Trading Up 0.4%

NASDAQ DOCU traded up $0.34 during trading hours on Thursday, hitting $76.24. The company's stock had a trading volume of 5,539,211 shares, compared to its average volume of 2,589,739. Docusign Inc. has a 52 week low of $54.31 and a 52 week high of $107.86. The company has a market capitalization of $15.41 billion, a PE ratio of 14.41, a price-to-earnings-growth ratio of 28.61 and a beta of 1.02. The company's 50-day simple moving average is $75.45 and its two-hundred day simple moving average is $79.53.

Docusign (NASDAQ:DOCU - Get Free Report) last posted its earnings results on Thursday, September 4th. The company reported $0.32 EPS for the quarter, missing the consensus estimate of $0.84 by ($0.52). Docusign had a return on equity of 14.27% and a net margin of 36.50%. Docusign has set its Q3 2026 guidance at EPS. FY 2026 guidance at EPS. Research analysts anticipate that Docusign Inc. will post 1.17 EPS for the current fiscal year.

Docusign declared that its board has approved a stock buyback program on Thursday, June 5th that permits the company to buyback $1.00 billion in outstanding shares. This buyback authorization permits the company to reacquire up to 6.6% of its shares through open market purchases. Shares buyback programs are often an indication that the company's leadership believes its shares are undervalued.

Wall Street Analyst Weigh In

A number of equities analysts have recently issued reports on DOCU shares. UBS Group cut their price objective on shares of Docusign from $85.00 to $80.00 and set a "neutral" rating on the stock in a research report on Friday, June 6th. Robert W. Baird cut their price objective on shares of Docusign from $93.00 to $85.00 and set a "neutral" rating on the stock in a research report on Friday, June 6th. Wells Fargo & Company raised shares of Docusign from an "underweight" rating to an "equal weight" rating and raised their price target for the company from $67.00 to $80.00 in a research report on Friday, June 13th. Wall Street Zen cut shares of Docusign from a "buy" rating to a "hold" rating in a research report on Saturday, August 2nd. Finally, JMP Securities reaffirmed a "market outperform" rating and issued a $124.00 price target on shares of Docusign in a research report on Tuesday, June 3rd. Four equities research analysts have rated the stock with a Buy rating and twelve have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of "Hold" and an average target price of $90.15.

Docusign Company Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.